Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[Al18F]PSMA137 PET/CT in Prostate Cancer
NCT04693169Active, not recruiting
- Sponsor
- Peking University Cancer Hospital & Institute
- Start
- Jan 2021
- Primary completion
- Jun 2024
- Countries
- 1
01
Overview
Open-label, single-arm trial, sponsored by Peking University Cancer Hospital & Institute. Primary endpoint: Standardized Uptake Value at 2 years. Started Jan 2021; status: active, not recruiting.
Beyond the preview
Go deeper on NCT04693169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04693169.